Aethlon Medical Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Aethlon Medical stock has a consensus rating of "Hold" and an average price target of $3.25. The average 1-year stock price forecast is 272.19% higher than the current stock price, while the lowest is $1.50 (+71.78%) and the highest is $5.00 (+472.61%).

Price Target: $3.25 (+272.19%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.50	$3.25	$3.25	$5.00
Change	+71.78%	+272.19%	+272.19%	+472.61%

Analyst Ratings

The average analyst rating for Aethlon Medical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Aug '25	Oct '25	Nov '25	Feb '26	Mar '26	Jun '26
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Hold Maintains $2	Hold	Maintains	$2	+129.04%	Jun 12, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Hold Maintains $1.5	Hold	Maintains	$1.5	+71.78%	Feb 17, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.23

from -10.61

EPS Next Year

-0.50

from -3.23

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	294.17K	574.25K	-	-	-	-
Operating Income	-10.42M	-11.90M	-12.64M	-9.34M	-7.29M	-7.98M
Net Income	-10.42M	-12.03M	-12.21M	-13.39M	-7.15M	-7.84M
EPS	-	-	-	-	-10.61	-3.23
Free Cash Flow	-6.22M	-7.02M	-6.49M	-4.89M	-4.54M	53.60M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2028	2029
High	-
Avg	-
Low	-

EPS Forecast

EPS	2027	2028	2029
High	-3.23
Avg	-3.23
Low	-3.23

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-